Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001072613-15-000073
Filing Date
2015-02-11
Accepted
2015-02-11 15:21:26
Documents
1
Group Members
ANTHONY A. FLORENCE JR.DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 14 GP LTDNEA PARTNERS 14 L.P.NEW ENTERPRISE ASSOCIATES 14 L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANRYAN D. DRANTSCOTT D.

Document Format Files

Seq Description Document Type Size
1 AURINIA PHARMACEUTICALS, INC. aurinia-sch13g_17752.htm SC 13G 583498
  Complete submission text file 0001072613-15-000073.txt   585533
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities Fund III, LLC (Filed by) CIK: 0001551055 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88628 | Film No.: 15599213
SIC: 2834 Pharmaceutical Preparations